# A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.

> **NCT06024213** · — · COMPLETED · sponsor: **BTG International Inc.** · enrollment: 101 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Sentinel lymph node identification
- **DRUG:** indocyanine green
- **DRUG:** methylene blue
- **DRUG:** Technetium (99mTc)

## Key facts

- **NCT ID:** NCT06024213
- **Lead sponsor:** BTG International Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-06
- **Primary completion:** 2023-11-06
- **Final completion:** 2023-12-19
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2024-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024213, "A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06024213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*